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Goats, Sheep, and 
Humans in the 
Netherlands
To the Editor: The 2007–2010 Q 
fever epidemic among humans in the 
Netherlands was among the largest 
reported in magnitude and duration 
(1). The increase in human Q fever 
cases coincided with an increase in 
spontaneous abortions among dairy 
goats in the southeastern part of the 
Netherlands, an area that is densely 
populated with goat farms (1). 
Genotypic analyses of the involved 
isolates could confi rm the possible 
link between the human and animal Q 
fever cases.
In previous studies, genotypic 
investigations of human and animal 
samples in the Netherlands were 
performed by using a 3-locus 
multilocus variable-number tandem 
repeats analysis (MLVA) panel and 
single-nucleotide polymorphism 
genotyping, respectively (2,3). The 
fi rst study, performed on relatively 
few samples from a minor part 
of the affected area, showed that 
farm animals and humans in the 
Netherlands were infected by different 
but apparently closely related 
genotypes. More recently, genotyping 
by using a 10-locus MLVA panel 
provided additional information about 
the genotypic diversity of Coxiella 
burnetii among ruminants in the 
Netherlands: 1 dominant MLVA 
genotype was identifi ed among goats 
and sheep throughout the entire 
affected Q fever area (4). A different 
panel of MLVA markers was applied 
to human samples (5). Four markers 
that are shared by both panels showed 
identical alleles in human and animal 
samples, again implicating goats 
and sheep as possible sources of the 
outbreak.
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MLVA, which is based on 
relatively unstable repetitive DNA 
elements, is sometimes criticized 
for producing results that are too 
discriminatory or diffi cult to reproduce 
in different settings (6). Because of 
their instability, use of tandem repeats 
as genotyping targets can lead to 
problems with data interpretation 
and to overestimation of genotypic 
diversity by showing small variations 
in MLVA genotypes in isolates of 
otherwise identical background.
We used a more stable, sequence-
based typing method, multispacer 
sequence typing (MST), on samples 
from humans and a group of ruminant 
animals (goats, sheep, and cattle) 
to establish a fi rmer correlation 
between Q fever cases in humans 
and animals (7). We identifi ed MST 
genotypes using a Web-based MST 
database (http://ifr48.timone.univ-
mrs.fr/MST_Coxiella/mst) containing 
genotypes from several countries in 
Europe. Ultimately, this study could 
answer the question of whether the 
current outbreak situation could have 
been caused by a specifi c C. burnetii 
strain in the ruminant population in 
the Netherlands.
Real-time PCR-positive speci-
mens from 10 humans and 9 Q 
fever–positive specimens from goats 
and sheep collected from various 
locations throughout the affected area 
were used (8). We also included Q 
fever-positive specimens from cattle 
to rule out cattle as a possible source 
of Q fever infection. Five samples 
of cow’s milk and 1 bovine vaginal 
swab sample were analyzed (online 
Appendix Table, wwwnc.cdc.gov/
EID/article/18/5/11-1907-TA1.htm). 
MST33 was identifi ed in 9 of 10 tested 
human samples and in the remaining 
8 of 9 clinical samples from goats 
and sheep (online Appendix Table). 
MST33 has been isolated incidentally 
in nonoutbreak situations in human 
clinical samples obtained in France 
during 1996, 1998, and 1999 and from 
a placenta of an asymptomatic ewe in 
Germany during 1992. All samples 
from cattle in the Netherlands, 1 goat, 
and cow’s milk contained genotype 
MST20. Genotype MST20 has also 
been identifi ed in human clinical 
samples from France, in a cow’s 
placenta from Germany isolated in 
1992 and in rodents from the United 
States isolated in 1958. In 1 human 
bronchoalveolar lavage sample, a 
novel (partial) MST genotype was 
found. This may be an incidental Q 
fever case unrelated to the outbreak 
situation. Because no historical 
genotyping data for the period 
before the outbreak of Q fever in 
the Netherlands are available, this 
explanation needs further research.
MST genotyping shows the 
presence of genotype MST33 in 
clinical samples from humans, goats 
and sheep. These results confi rm that 
goats and sheep are the source of 
human Q fever in the Netherlands. 
Few worldwide genotyping studies 
have been conducted, and therefore 
information about a possible global 
persistence of this genotype is lacking. 
This study also indicates that the 
outbreak among humans is not linked 
to C. burnetii in cattle, although 
the infection is widespread among 
dairy herds in the Netherlands (10), 
exemplifying that most outbreaks are 
related to goats and sheep rather than 
to cattle. In conclusion, the increase 
in the number of Q fever cases in 
the Netherlands among humans most 
likely results from MST33 in the 
goat population in the Netherlands 
and could have been facilitated by 
intensive goat farming in the affected 
area and its proximity to the human 
population.
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Titers and Hidden 
Leprosy Cases, 
Amazon Region
To the Editor: Leprosy remains 
a serious public health issue. Although 
the World Health Organization 
elimination target was achieved 
in 2000, with a prevalence of <1 
case/10,000 persons, despite progress 
since introduction of multidrug therapy 
(1), large pockets of poverty remain 
in which the disease is hyperendemic 
and underdiagnosed. In fact, in highly 
disease-endemic areas, the prevalence 
of previously undiagnosed leprosy 
cases in the general population has 
been reported to be 6× higher than the 
registered prevalence (2).
Most leprosy patients are in 
India and Brazil. In Brazil, new cases 
are concentrated in the Northeast, 
Midwest, and Amazon regions (from 
state capitals to the inner counties). 
Access to the health system is poor 
in these regions because of severe 
inequalities in the public health 
system of Brazil (3),
A total of 34,894 new cases were 
registered in Brazil during 2010 (4), 
corresponding to an incidence rate of 
18.22 cases per 100,000 population. 
Pará State accounted for 10.2% of 
cases (3,562 cases), an incidence rate 
of 46.93 per 100,000 population. When 
only children <15 years of age were 
considered, Pará registered 389 new 
cases of leprosy in 2010, representing 
10.9% of all cases, an incidence rate 
of 16.52 per 100,000 population. 
In Oriximiná, a county with 62,794 
inhabitants in northwestern Pará, ≈800 
km from Belém, Pará’s capital, a mean 
of 13.8 cases per year were registered 
for the past 5 years.
In 2010, in Oriximiná, we 
collected plasma samples from 138 
students 8–18 years of age, from 
35 leprosy patients who received 
a diagnosis during 2004–2009, 
and from 126 contacts of these 
patients (Federal University of 
Pará Research Ethics Committee 
protocol no. 197/07). We tested all 
of these samples for anti–phenolic 
glycolipid-I (PGL-I) IgM; 42% of 
students, 54.3% of case-patients, and 
45% of case-patient contacts were 
seropositive. In addition to collecting 
samples, we clinically examined the 
leprosy patients and their contacts, 
among whom we identifi ed 3 new 
leprosy cases. We did not examine 
students at that time. Contacts were 
persons from the same household 
or neighborhood whom the index 
case-patient described as a person 
with whom he or she had a close 
relationship. Leprosy cases were 
diagnosed in the fi eld on the basis 
of clinical signs, loss of sensation 
on the skin lesions, and presence 
of enlarged nerves. For operational 
reasons, skin smears were not 
performed. All cases were diagnosed 
by 2 leprologists. We used the Ridley-
Jopling classifi cation, associated with 
the indeterminate clinical type, as 
defi ned by the Madrid classifi cation. 
The ELISA cutoff for positive results 
was arbitrarily established as an 
optical density of 0.295 based on the 
average plus 3× the SD of the test 
results from 14 healthy persons from 
the Amazon region (5).
Because studies of the 
seroprevalence among contacts have 
reported a proportion of seropositive 
persons ranging from ≈1.9% to 
18.4% (6), we returned to Oriximiná 
16 months after the fi rst visit. We 
examined 2 groups of students and 
their contacts; 1 group was positive 
for anti–PGL-I, and the other group 
was negative for anti–PGL-I. We 
visited 44 households in 1 week. From 
the 35 leprosy patients encountered 
during the fi rst visit, we selected 25 
households to survey (14 with an 
anti–PGL-I–positive contact in the 
household and 11 without), and among 
students with results of anti–PGL-I 
serology, we selected 19 households 
(11 positive with an anti–PGL-I–
positive contact in the household and 
8 without). During our visits to all of 
these households, we examined 222 
persons (Table).
When we arrived in Oriximiná, 
only 2 cases had been registered 
in the national notifi able diseases 
information system. By using our 
approach, 23 new cases were found 
after we investigated households 
that had a person positive for 
anti–PGL-I (15 multibacillary, 8 
paucibacillary); we found only 7 new 
cases in households where residents 
were negative for anti–PGL-I (4 
multibacillary, 3 paucibacillary) 
(Table). For comparison, during the 
last traditional leprosy campaign in 
Oriximiná in 2008, eight new cases 
were detected. Furthermore, by using 
our strategy, the local public health 
service detected 9 additional new 
cases during the 4 months after our 
departure from Oriximiná.
These data emphasize that 
contact examination is crucial for 
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